1.33B
Market cap
Current P/E
27.47x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners.

Similar securities

Based on sector and market capitalization

Report issue